Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
25.92
-0.41 (-1.56%)
May 28, 2025, 4:00 PM - Market closed
Harrow Employees
Harrow had 382 employees as of December 31, 2024. The number of employees increased by 67 or 21.27% compared to the previous year.
Employees
382
Change (1Y)
67
Growth (1Y)
21.27%
Revenue / Employee
$557,220
Profits / Employee
-$56,796
Market Cap
951.25M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
HROW News
- 14 hours ago - Harrow: Epic Growth & Operating Leverage On Full Display - Seeking Alpha
- 14 days ago - Harrow to Present at Two Investor Conferences in May - Business Wire
- 18 days ago - Harrow, Inc. (HROW) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Harrow Announces First-Quarter 2025 Financial Results - Business Wire
- 23 days ago - Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025 - Business Wire
- 4 weeks ago - NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. - PRNewsWire
- 6 weeks ago - Harrow Expands VEVYE® Access for All Program to ImprimisRx's Klarity-C Patients - Business Wire
- 2 months ago - Harrow: When Cheaper Doesn't Mean Attractive (Rating Upgrade) - Seeking Alpha